New Lundbeck CEO reviews strategy: "It’s important to recognize where our strengths are"
On September 1, Charl van Zyl took over the top management of Lundbeck, and on Wednesday he presented financial results for the first time – with sales growth in all four of Lundbeck’s key products, Rexulti, Abilify Maintena, Brintellix/Trintellix and Vyepti.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.